Evidence map›Paper›PMID 37459318›Full record

ArticlePloS one2023

The micro-economic effects of COVID-19 containment measures: A simple model and evidence from China.

Wenxuan Chen, Songlei Chao, Jianliang Ye

Abstract read
In one paragraph

Article in PloS one, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Wenxuan ChenResearch Center for Intelligent Society and Governance, Research Institute of Interdisciplinary Innovation, Zhejiang Lab, Hangzhou, Zhejiang, China.
Songlei ChaoResearch Center for Intelligent Society and Governance, Research Institute of Interdisciplinary Innovation, Zhejiang Lab, Hangzhou, Zhejiang, China.ORCID 0000-0002-1397-3579
Jianliang YeSchool of Economics, Zhejiang University, Hangzhou, Zhejiang, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Optimizing the trade-off between economic growth and public health is a major goal of public administration, especially during public health events. Although containment measures are widely used to combat the Covid-19 outbreak, it is still debated how the measures affect the economy. Using a simplified susceptible-infected-recovered (SIR) model, this study investigates the dynamic impact of lockdown policy on social costs during the epidemic and the underlying mechanism, revealing that the lockdown policy has both a "shutdown effect" and an "anti-epidemic effect", and should be implemented and lifted in a timely manner. Based on a micro-level dataset of 57,547 private enterprises in China in 2020, this study provided empirical evidence for the presence of negative "shutdown effect" and positive "anti-epidemic effect" of lockdown on reopening, both of which are in part mediated by labor input, factor mobility, and market demand recovery. Furthermore, the shutdown effect is weaker in regions with sufficient testing and quarantine resources, government capacity and preference for targeted response, whereas the anti-epidemic effect is stronger in densely populated areas with relatively low public compliance. Additionally, digital measures can aid in the containment of epidemics. The findings not only contribute to a better understanding of the rationality and effectiveness of the lockdown policy, but also provides practical evidence and implications for the government to improve the synergistic efficiency of epidemic control tools and strengthen the resilience of local economic growth.

Indexed as

COVID-19ChinaCommunicable Disease ControlHumansQuarantineSARS-CoV-2

Identifiers

PMID37459318
PMCPMC10351727

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.